Skip to content

Human Pharmacokinetic Study of Panax Notoginseng Extract

Human Pharmacokinetic Study of Panax Notoginseng Extract

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-09000382
Enrollment
Unknown
Registered
2009-04-22
Start date
2008-08-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Interventions

Only one group:~1 ml blood were taken from an antecubital vein catheter at 0, 0.5, 1.5, 3, 4.5, 8, 12, 15, 25, 30, 38, and 49 h after oral adminisrateion of Panax notoginseng extract at 35 ml/subject.

Sponsors

Shanghai Institute of Materia Medica, Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
21 Years to 29 Years

Inclusion criteria

Inclusion criteria: (1) Healthy human subjects between 20 to 30 years old with body mass index not exceeding the ideal value more than 15%; (2) Subjects must understand the purpose, character, procedures of the pharmacokinetic study, as well as the characteristics of Panax notoginseng extract. Subject should participate in the study of his own accord and sign Informed Consent Form prior to this study.

Exclusion criteria

Exclusion criteria: (1) Subjects who took any over-the-counter or prescription drugs within two weeks or any alcohol-, caffeine-, tea-, or citrus-containing beverages or foods within two days; (2) Subjects who participated any investigational drug study within 3 months prior to this study; (3) In the opinion of the investigator, subjects who are not suitable to participate in the study for whatever reasons must be excluded.

Design outcomes

Primary

MeasureTime frame
Drug concentration in urine;Drug concentration in blood;

Contacts

Public ContactChuan Li
chli@mail.shcnc.ac.cn+86 021 50803106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026